WO2012130999A9 - Peptides isolated and purified from fruit bat testicles - Google Patents

Peptides isolated and purified from fruit bat testicles Download PDF

Info

Publication number
WO2012130999A9
WO2012130999A9 PCT/EP2012/055724 EP2012055724W WO2012130999A9 WO 2012130999 A9 WO2012130999 A9 WO 2012130999A9 EP 2012055724 W EP2012055724 W EP 2012055724W WO 2012130999 A9 WO2012130999 A9 WO 2012130999A9
Authority
WO
WIPO (PCT)
Prior art keywords
testicles
purified
fruit bat
peptides isolated
isolated
Prior art date
Application number
PCT/EP2012/055724
Other languages
French (fr)
Other versions
WO2012130999A1 (en
Inventor
Pierrïck AUVRAY
Elise DUVAL
Amandine BARON
Cécile CHAUVIN
Vincent HESRY
Déborah JOUQUAN
Mélanie MARTIN
Emma REDON
Pascal SOURDAINE
Frédéric BOURGEON
Nathalie MELAINE
Charles Pineau
Astrid Rouillon
Adrien BOSSEBOEUF
Original Assignee
Kelia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kelia filed Critical Kelia
Publication of WO2012130999A1 publication Critical patent/WO2012130999A1/en
Publication of WO2012130999A9 publication Critical patent/WO2012130999A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to bioactive peptides that have been isolated and purified from fruit bat testicles, to the use thereof as a drug, in particular to the use thereof for preventing and treating cancer.
PCT/EP2012/055724 2011-04-01 2012-03-29 Peptides isolated and purified from fruit bat testicles WO2012130999A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1152786 2011-04-01
FR1152786A FR2973380B1 (en) 2011-04-01 2011-04-01 ISOLATED AND PURIFIED PEPTIDES FROM ROUSSETTE TESTICLES

Publications (2)

Publication Number Publication Date
WO2012130999A1 WO2012130999A1 (en) 2012-10-04
WO2012130999A9 true WO2012130999A9 (en) 2013-10-31

Family

ID=45928896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/055724 WO2012130999A1 (en) 2011-04-01 2012-03-29 Peptides isolated and purified from fruit bat testicles

Country Status (2)

Country Link
FR (1) FR2973380B1 (en)
WO (1) WO2012130999A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10344799A1 (en) * 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy

Also Published As

Publication number Publication date
FR2973380B1 (en) 2018-02-09
FR2973380A1 (en) 2012-10-05
WO2012130999A1 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
NZ708727A (en) Conjugate compounds
MD4589B1 (en) Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2013072813A3 (en) Cytotoxic peptides and antibody drug conjugates thereof
WO2012062925A3 (en) Compounds and methods for treating pain
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
EP2873678A4 (en) Cell-penetrating peptide, conjugate comprising same and composition comprising same
PL2672966T3 (en) Pharmaceutical composition, methods for treating and uses thereof
WO2012103059A3 (en) Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
SG10201903119QA (en) Polypeptide vaccine
IL225597A0 (en) Pharmaceutical composition, methods for treating and uses thereof
HUE054621T2 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2753348A4 (en) A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate
EP2699584A4 (en) Cyclic peptide from nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
MX357284B (en) Quinone compounds for treating ape1 mediated diseases.
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
HK1192726A1 (en) 1,2,4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases 124--5-
HK1204615A1 (en) (1r,4r)7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof (1r4r)7--2-[222]-5-
WO2011130692A3 (en) Androgen induced oxidative stress inhibitors
WO2014039074A3 (en) Therapeutic compositions and related methods
MX2013003168A (en) Anti-ephrin-b2 antibody and use thereof.
WO2014172309A3 (en) Therapeutic compositions for neutralizing type i interferons, and methods of use
WO2013081420A3 (en) Phenoxypropanol derivative and pharmaceutical composition containing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12711873

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12711873

Country of ref document: EP

Kind code of ref document: A1